Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis

Author： Viigimaa Margus Abina Jelena Zemtsovskaya Galina Tikhaze Alla Konovalova Galina Kumskova Elena Lankin Vadim

ISSN： 0803-7051

Source： Blood Pressure, Vol.19, Iss.3, 2010-06, pp. : 164-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The effect of oxidatively modified low-density lipoproteins on platelet aggregability and membrane fluidity

By Vlasova I. I.

Platelets, Vol. 11, Iss. 7, 2000-11 ,pp. : 406-414

Informa Healthcare

Access to resources Recommend Favorite

Effects of malondialdehyde content in low density lipoproteins on platelet adhesion

By Suttnar J. Otáhalová E. Čermák J. Dyr J. E.

Platelets, Vol. 17, Iss. 2, 2006-03 ,pp. : 92-99

Informa Healthcare

Access to resources Recommend Favorite

Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function

By Opper C. Schussler G. Sattler W. Malle E.

Platelets, Vol. 9, Iss. 5, 1998-10 ,pp. : 339-340

Informa Healthcare

Access to resources Recommend Favorite

Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis

By Simonini G. Falcini F. Generini S. Pignone A. Cerinic M.M.

European Journal of Internal Medicine, Vol. 11, Iss. 5, 2000-10 ,pp. : 289-289

Elsevier

Access to resources Recommend Favorite

Small Dense Low-Density Lipoproteins and Associated Risk Factors in Patients with Stroke

Cerebrovascular Diseases, Vol. 27, Iss. 1, 2008-11 ,pp. : 99-104

Karger

Access to resources Recommend Favorite